Workplace asthma costs UK at least $158 million a year
Costs of occupational asthma in the UK
2010-11-25
(Press-News.org) Workplace asthma costs the UK at least £100 million a year, and may be as high as £135 million, reveals research published online in Thorax.
An estimated 3,000 new cases of occupational asthma are diagnosed every year in the UK, but the condition is under diagnosed, say the authors.
They reviewed published data on the costs of all asthma and workplace asthma, as well as the impact costs.
The evidence was then used to calculate the costs of workplace asthma on an individual's ability to work and their wider life, including their use of health services, based on a series of six likely scenarios.
These included a male and female employee who developed asthma after being exposed to one of three likely and common sources. These were: isocyanates, used in products such as insulation, paints, car seats, underlay, and laminate; latex (gloves used in healthcare); and flour or grain.
The financial impacts were then divided up among those likely to be borne by the individual, the employer, and the state. Direct costs, such as use of healthcare and benefits; indirect costs, such as lost income and productivity; and employer costs were added together to come up with a total cost generated over time at 2003 prices.
The authors calculated that the true costs lay between £72 and £100 million over the life course of those affected, or £3.4 to £4.8 million a year. The costs for male employees were more than twice those for female employees.
But taking account of an underestimation of occupational asthma diagnosis by a third, the total could be closer to £135 million, suggest the authors.
Half the costs fall on the individual; just under half falls on the state. But only 3-4% falls on employers.
The authors suggest that there is scope for huge savings to be made if steps were taken to reduce the levels of exposure to agents which cause workplace asthma.
"The findings also suggest that the employer should bear more responsibility for establishing approaches to disease reduction by introduction of appropriate exposure control interventions and changes in work processes," they conclude.
INFORMATION: END
ELSE PRESS RELEASES FROM THIS DATE:
2010-11-25
New research from the Emory University School of Medicine offers reassurance for nursing mothers with epilepsy. According to a study published in the November 24 online issue of Neurology, the medical journal of the American Academy of Neurology, breastfeeding a baby while taking a seizure medication may have no harmful effect on the child's IQ later in life.
"Our results showed no difference in IQ scores between the children who were breastfed and those who were not," says study author Kimford Meador, MD, professor of neurology, Emory University School of Medicine and ...
2010-11-25
Chronic jet lag alters the brain in ways that cause memory and learning problems long after one's return to a regular 24-hour schedule, according to research by University of California, Berkeley, psychologists.
Twice a week for four weeks, the researchers subjected female Syrian hamsters to six-hour time shifts – the equivalent of a New York-to-Paris airplane flight. During the last two weeks of jet lag and a month after recovery from it, the hamsters' performance on learning and memory tasks was measured.
As expected, during the jet lag period, the hamsters had trouble ...
2010-11-25
Toronto, ON – November 24 – It's never fun riding the bench – but could it also make you less likely to be physically active in the future?
That's one of the questions being explored by Mark Eys, an associate professor of kinesiology and physical education at Wilfrid Laurier University and the Canada Research Chair in Group Dynamics and Physical Activity. Eys is presenting his work as part of this week's Canada Research Chairs conference in Toronto.
Eys, who also teaches out of the university's psychology department, is studying group cohesion – which, in sporting ...
2010-11-25
Bonn, 24th November 2010. Metformin, a drug used in type 2-diabetes might have the potential to also act against Alzheimer's disease. This has been shown in a study from scientists of the German Center for Neurodegenerative Diseases (DZNE), the University of Dundee and the Max-Planck-Institute for Molecular Genetics. The researchers have found out that the diabetes drug metformin counteracts alterations of the cell structure protein Tau in mice nerve cells. These alterations are a main cause of the Alzheimer's disease. Moreover, they uncovered the molecular mechanism of ...
2010-11-25
You may think of your love for your mate as the noble emotion of a pure heart, but some primitive parts of your brain are taking a decidedly more pragmatic approach to the subject, according to Stanford biologists.
In experiments with African cichlid fish, the scientists discovered that when a female shows a preference for a particular male, but then witnesses him losing a fight with another male, her feelings toward him change.
Areas of the female's brain associated with anxiety showed increased activity after witnessing an altercation.
"It is the same as if a woman ...
2010-11-25
An international team of immunologists studying the effects of cannabis have discovered how smoking marijuana can trigger a suppression of the body's immune functions. The research, published in the European Journal of Immunology, reveals why cannabis users are more susceptible to certain types of cancers and infections.
The team, led by Dr Prakash Nagarkatti from the University of South Carolina, focused their research on cannabinoids, a group of compounds found inside the cannabis plant, including THC (delta-9 tetahydrocannabinol) which is already used for medical ...
2010-11-25
As the eurozone continues to wobble, new analysis of countries' economic interconnectedness finds that some of the countries with the greatest potential to cause a global crash have surprisingly small gross domestic production.
Using data from Bureau Van Dijk - the company information and business intelligence provider - to assess the reach and size of different countries' economies, and applying the Susceptible-Infected-Recovered (SIR) model, physicists from universities in Greece, Switzerland and Israel have identified the twelve countries with greatest power to spread ...
2010-11-25
Fifty-seven laboratories from 29 countries volunteered to put their measuring competence to the test. Each laboratory received a sample without knowing the levels of heavy metals present, and was asked to measure and report the values back to the JRC.
The good results should enhance consumers' confidence, as maximum levels of lead, cadmium and total mercury in seafood are regulated by EU law and it has been proven that most participants are able to correctly measure them. In addition, this comparison has highlighted other issues, such as the apparent dependency of the ...
2010-11-25
About 30% of breast cancer patients have tumours that show rapid growth and invasion through the body. A common denominator in all of these cases is the presence of a large number of Her2 proteins in tumour cellular membranes. Consequently, these aggressive tumours are referred to as HER2+. Scientists working in the Metastasis Laboratory (MetLab) at IRB Barcelona headed by ICREA researcher Roger Gomis, have described the molecular mechanism that induces HER2+ tumours to ignore the signals that protect cells from excessive growth. The study is published this week in the ...
2010-11-25
In the wake of devastating cholera outbreaks in refugee camps in earthquake-wracked Haiti, a group of leading experts from Harvard Medical School, George Washington University, and the International Vaccine Institute (IVI) have urged the United States to create an emergency stockpile of cholera vaccines for future humanitarian use.
"The costs to the U.S. of creating and maintaining a stockpile of several million doses of cholera vaccine would be low," said the experts in an article published online first on November 24 in The New England Journal of Medicine (NEJM). "But ...
LAST 30 PRESS RELEASES:
[Press-News.org] Workplace asthma costs UK at least $158 million a year
Costs of occupational asthma in the UK
